Predicting the Risk of Melanoma Metastasis Using an Immune Risk Score in the Melanoma Cohort

Melanoma is a highly aggressive cancer, attracting increasing attention worldwide. The 5-year survival rate of patients with metastatic melanoma is low. Therefore, it is critical to identify potential effective biomarkers for diagnosis of melanoma metastasis. In the present study, the melanoma cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Yang, Yanping, Cheng, Tong, Liu, Ning, Liu, Yufeng, Liu, Geyu, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136491/
https://www.ncbi.nlm.nih.gov/pubmed/32296685
http://dx.doi.org/10.3389/fbioe.2020.00206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136491/
https://www.ncbi.nlm.nih.gov/pubmed/32296685
http://dx.doi.org/10.3389/fbioe.2020.00206

Ejemplares similares